These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 6354090

  • 21. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A, Kniest F, Menzel A, Meyer H, Sprung V.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract] [Full Text] [Related]

  • 22. Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study.
    Osterballe O, Løwenstein H, Norn S, Prahl P, Skov P, Skov PS, Weeke B.
    Allergy; 1982 Oct; 37(7):491-501. PubMed ID: 7181048
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Masamoto T, Yamada K, Nakai Y, Ohmoto Y.
    Acta Otolaryngol Suppl; 1998 Oct; 538():143-51. PubMed ID: 9879414
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M.
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Hyposensitization therapy: current status].
    Fiandor Román AM, Pascual Marcos C.
    An Esp Pediatr; 1985 Apr 15; 22(5):345-8. PubMed ID: 2409854
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Short-term immunotherapy--a survey of current studies].
    Rasp G, Klimek L.
    Wien Med Wochenschr; 1999 Apr 15; 149(14-15):403-9. PubMed ID: 10584283
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C, Ma Y, Wopfner N, Gadermaier G, Dedic A, Niggemann B, Maderegger B, Gruber P, Ferreira F, Scheiner O, Hoffmann-Sommergruber K.
    Int Arch Allergy Immunol; 2008 Apr 15; 145(2):94-101. PubMed ID: 17823540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.